Average Co-Inventor Count = 12.24
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. British Columbia Cancer Agency Branch (10 from 65 patents)
2. The United States of America, as Represented by the Secretary, Department of Health and Human Services (7 from 3,540 patents)
3. Universität De Barcelona (7 from 47 patents)
4. The University of Arizona (6 from 975 patents)
5. Hospital Clinic De Barcelona (6 from 21 patents)
6. Oslo University Hospital Hf (6 from 11 patents)
7. University of Nebraska (5 from 937 patents)
8. Julius-Maximilians-University of Wurzburg (5 from 6 patents)
9. University of Rochester (4 from 975 patents)
10. Oregon Health & Science University (4 from 509 patents)
11. University of London (4 from 89 patents)
12. The Cleveland Clinic Foundation (2 from 1,041 patents)
13. Fundacio Clinic (2 from 2 patents)
14. Mayo Foundation for Medical Education and Research (1 from 1,747 patents)
15. Hospital Clinic (1 from 1 patent)
10 patents:
1. 11725248 - Evaluation of mantle cell lymphoma and methods related thereto
2. 11574704 - Method for subtyping lymphoma types by means of expression profiling
3. 11326212 - Biomarkers for non-hodgkin lymphomas and uses thereof
4. 11028444 - Survival predictor for diffuse large B cell lymphoma
5. 10697975 - Methods for identifying, diagnosing, and predicting survival of lymphomas
6. 10607717 - Method for subtyping lymphoma types by means of expression profiling
7. 10113199 - Biomarkers for non-hodgkin lymphomas and uses thereof
8. 9970059 - Survival predictor for diffuse large B cell lymphoma
9. 9045801 - Biomarkers for non-hodgkin lymphomas and uses thereof
10. 8131475 - Methods for identifying, diagnosing, and predicting survival of lymphomas